ΚΑΡΔΙΑΚΗ ΑΝΕΠΑΡΚΕΙΑ ΜΕ ΔΙΑΤΗΡΗΜΕΝΟ ΚΛΑΣΜΑ ΕΞΩΘΗΣΗΣ
|
|
- Merryl Henry
- 6 years ago
- Views:
Transcription
1 ΚΑΡΔΙΑΚΗ ΑΝΕΠΑΡΚΕΙΑ ΜΕ ΔΙΑΤΗΡΗΜΕΝΟ ΚΛΑΣΜΑ ΕΞΩΘΗΣΗΣ ΙΓΝΑΤΙΟΣ ΟΙΚΟΝΟΜΙΔΗΣ MD, PHD, FESC ΑΝΑΠΛΗΡΩΤΗΣ ΚΑΘΗΓΗΤΗΣ ΚΑΡΔΙΟΛΟΓΙΑΣ Β ΚΑΡΔΙΟΛΟΓΙΚΗ ΚΛΙΝΙΚΗ, ΕΘΝΙΚΌ ΚΑΙ ΚΑΠΟΔΙΣΤΡΙΑΚΌ ΠΑΝΕΠΙΣΤΗΜΙΟ ΑΘΗΝΩΝ ΝΟΣΟΚΟΜΕΙΟ ΑΤΤΙΚΟΝ
2 HFPEF: definition ESC 2005 A diagnosis of primary diastolic heart failure requires three obligatory conditions to be simultaneously satisfied: (1) presence of signs or symptoms of congestive heart failure; (2) presence of normal or only mildly abnormal left ventricular systolic function; (3) evidence of abnormal left ventricular relaxation, filling, diastolic distensibility or diastolic stiffness ESC 2012 ACC/AHA 2013 HF definition HFPEF definition Abnormality of cardiac structure or function leading to failure of the heart to deliver oxygen at a rate commensurate with the requirement of the metabolizing tissues, despite normal filling pressure (or only at the expense of increased filling pressures) Requires 4 conditions to be satisfied Typical symptoms of HF Typical signs of HF Preserved ejection fraction (EF 45%) and left ventricle not dilated Relevant structural heart disease and/or diastolic dysfunction Complex clinical syndrome that results from any structural or functional impairment of ventricular filling or ejection of blood Stage C heart failure Known structural heart disease Typical signs and symptoms Preserved ejection fraction (EF 50% HF-PEF, EF 41% 50% borderline HF-PEF)
3 In Epidemiology studies among subjects without HF, 28.1% have some degree of LV diastolic dysfunction 70% in HfpEF worsening of LV diastolic dysfunction is associated with an increased risk of developing HF JAMA 2003; 289:194 JAMA 2011; 306:856.
4 Heterogeneity of HFPEF in Registries and RCTs Registries RCTs LVEF at inclusion 40%, > 50% 40%, >45%, 50% Mean LVEF 58% - 62% 55% - 67% Median NT-proBNP 602pg/ml 1840 pg/ml 158 pg/ml 887 pg/ml % Hypertension % AF % DM % CAD ADHERE OPTIMIZE Swedish HF Registry IN-HF registry PEP-CHF RELAX DIG PARAMOUNT CHARM-preserved I-Preserve TOPCAT Aldo-DHF
5 ALARM REGISTRY: LVEF % By AHF Classification 100% 80% 60% 40% 20% 0% Avg LVEF %/EHS HF II 38/38% 38/37% 39/40% 32/33% 48/44% 44/48% 44% 16% 32% 29% 33% 37% 62% 53% 44% 43% 45% 46% 31% 41% 46% 27% 25% 26% 21% 11% 17% 15% All AHF ADHF P-OE Cardiogenic HYP AHF RV AHF High output shock LVEF <30% LVEF 30-44% LVEF >=45% Sample = 3,283 AHF patients with specified LVEF value Parissis J, Ikonomidis I on behalf of the ALARM Steering Committee, Am J Cardiol
6 HFPEF: Current state of the problem A significant health problem: ~50% of all HF cases Mortality: In-hospital 3%, annual 11%, 5-y 55% Increasing hospitalization rates compared to HFREF Mortality rates higher, more similar to HFREF, after hospitalization
7 Oktay et al, Curr Heart Fail Rep 2013
8 HFPEF: causes 1. Cardiovascular risk factors: Arterial hypertension, Diabetes mellitus, Obesity, Atrial fibrillation, CAD, ageing 2. Non-cardiovascular risk factors: Renal impairment, chronic lung diseases, anemia, cancer, liver disease, peptic ulcer disease, hypothyroidism 2. Hypertophic cardiomyopathy 3. Valvular diseases 4. High-output HF (anemia, hyperthyroidism, liver disease, AV fistula) 5. Infiltrative disorders (e.g. amyloidosis, sarcoidosis) 6. Myocardial storages diseases (e.g. haemochromatosis) 7. Endomyocardial disease (e.g. radiation) Lam CS, EJHF 2010 K McDonald. Int J Cardiol 2008
9 A heterogeneous pathophysiology a heterogeneous syndrome Senni M, et al. EHJ 2014
10
11 Pathophysiology of HFPEF: Diastolic dysfunction Ox stress/ NO bioavailability Stiff titin isoform Calcium overload Prolonged LV relaxation Reduced LV compliance Borlaug BA, Nat Rev Cardiol 2014
12
13 CALCULATION OF LV FILLING PRESSURE OR PCWP E/A= DT= ms IVRT=70-90 ms E/A<0.75 DT>240 ms IVRT>90 ms E/A= DT= ms IVRT<90 ms E/A>1.5 DT<160 ms IVRT<70 ms Mean Ε/Ε >13 ΜEAN LVDP <15 mmhg ΜEAN LVDP =15-25 mmhg ΜEAN LVDP >25 mmhg
14
15 LA Volumes Paulus W J et al. Eur Heart J 2007;28:
16 J Am Soc Echocardiogr 2016;29:
17 Diastolic stress test
18 Role of BNP/exercise in Diagnosis
19 Diastolic stress test J Am Soc Echocardiogr 2016;29:
20 DEVELOPMENT OF HF IN DIABETICS
21 VA COUPLING TO DIAGNOSE HEFPEF J Am Coll Cardiol 2013;61:
22 Doppler-Tissue Doppler Imaging Mitral annulus velocities-strain rate Technical difficulties Angle dependent Load dependent Interference-noise Time consuming analysis Great interobserver variability Any alternative?
23 Impaired Systolic Function by Strain Imaging in HFpEF 219 HFpEF patients Ιmpaired systolic function GLS, GCS despite preserved global LVEF in HFpEF Kraigher-Krainer et al. J Am Coll Cardiol 2014;63:447 56
24 Ikonomidis I et Eur J Heart Fail 2015 Diastolic suction Control ptw Δ1:33% UntwMVO Δ2:79% A A Hypertensive ptw Δ1:26 % Δ2:64 % B UntwMVO UtwEDF UtwEDF MVO MVO EDF EDF
25 Exercise capacity in hypertensives A reverse association between PWV and VO2PEAK was revealed in hypertensives with delayed BPRR Increased LV untwisting rate was associated with increased NTproBNP and reduced VO2 peak Triantafyllidi H, Ikonomidis I Blood Pressure Monit, 2013 Ikonomidis I, Eur J Heart Failure 2015
26 NORMAL Ikonomidis I Heart 2009, Circulation Cardiovasc Imaging 2014 RA no CAD
27 Healthy MV O 33 % E E F 75 % IMPAIRED GLS AND TWISTING IN R.ARTHRITIS 70 msec Ikonomidis et al Circulation Cardiovascular Imaging 2015 RA without CAD MV O 26 % EE F 64 % RA with CAD MV O 20 % EE F 50 % 85 msec 100 msec
28 Association of GLS with fibrosis in HCM Fibrosis related to risk of sudden death European Heart Journal Cardiovascular Imaging (2012) 13,
29 Apical sparing for diagnosis of c.amyloidosis vs other causes of LVH Phelan et al. Heart 2012;98: GLS= -7.8%
30 LA assessment Differentiates HT- HCM vs normal controls a c MVO v MVO c a v Paraskevaidis, Ikonomidis Heart 2008
31 LA STRAIN pre-post cardioversion
32 2D STRAIN pre-post cardioversion
33 NOVEL INDICES OF LV DIASTOLIC FUNCTION J Am Soc Echocardiogr 2016;29:
34 Predictors of rehospitalisation and CV death in HEFPEF
35 Patients with a composite of abnormal TDI indices for LV function and preserved EF had an increased mortality (survival rate 37%) compared to patients with normal TDI markers (survival rate 83%) (log rank=11,1 p=0.001,). Composite of S <8 cm/s E 8cm/sec and/or mean E/E 13 Ikonomidis I Shock 2010
36 Tissue Doppler Imaging as a Prognostic Marker for Cardiovascular Events in Heart Failure with Preserved Ejection Fraction and Atrial Fibrillation J Am Soc Echocardiogr 2010;23:
37 LA strain the strongest predictor of CV events Circulation: Cardiovascular Imaging.2016; 9: e00375
38 Incremental Value of Deformation Indices for Predicting Subsequent Reduction in EF>10% at 1year post chemotherapy ΔGLS>11% at 6m ΔGLS>10% at 3m* J Am Soc Echocardiogr 2013;26: *Heart 2010;96:701 7.
39 GLS is a strong independent predictor of all-cause mortality in patients with AOS pef GLS detects subclinical dysfunction and has incremental prognostic value over traditional risk markers including haemodynamic severity, symptom class, and LVEF in patients with AS. Independent predictor of all-cause mortality (HR: 1.38, P=0.001) Incorporation of GLS into risk models may improve the identification of the optimal timing for AV replacement. European Heart Journal Cardiovascular Imaging 2012;13:
40 Early Diastolic Strain Rate in Relation to Systolic and Diastolic Function and Prognosis in Aortic Stenosis Figure 1. Example of Measurement of E/SReMeasurements are shown of early mitral inflow velocity (E) using pulsewave Doppler and early diastolic strain rate (SRe) from 2D speckle tracking. AVC = aortic valve closure. Jordi S. Dahlb E. Møller JACC: Cardiovascular Imaging, Volume 9, Issue 5, 2016,
41 Strain -AoRergurgitation Am J Cardiol. 2012;110(7): J Am Soc Echocardiogr. 2011;24(11): GLS 17.5 ± 3.1% before AVR >-19.5%, sens: 77%,spec:94% for progressive AR >-11.5%, impaired outcome post AVR
42 GLS predicts LV dysfunction after mitral valve repair cut-off value LV GLS 19.9% predicts long-term postoperative LV dysfunction sensitivity 90% specificity 79% A GLS of independent predictor of long-term LV dysfunction after adjustment for parameters currently implemented into guidelines. European Heart Journal Cardiovascular Imaging 2012
43
44 conclusions HFpEF is a clinical diagnosis that is assisted by echocardiography evaluation The pathophysiology of the syndrome is multi-factorial and only partly understood Diuretics remain the only recommended therapy for HFpEF Encasement of CGMP,serelaxin LCZ promising results
45 Serelaxin in AHF: preserved EF vs reduced EF RELAX-AHF 1161 AHF pts SBP >125 mmhg Serelaxin, recombinant human relaxin 2, 48-hour iv or placebo Filippatos, Teerlink, Farmakis et al, Eur Heart J 2014
46 RESTRICTIVE CARDIOMYOPATHY
47 Restrictive
48 Apical sparing for diagnosis of c.amyloidosis vs other causes of LVH Phelan et al. Heart 2012;98: GLS= -7.8%
49 Increased benefit of IL-1 inhibition in RA-CAD Anakinra:IL-1ra Ikonomidis I Lekakis J. Circulation Cardiovasc Imaging 2014
50
51 Phenotypes of HFPEF based on clinical presentation EXERCISE-INDUCED DIASTOLIC DYSFUNCTION Exercise intolerance NYHA II Minimal fluid retention No HF hospitalization BNP normal/mildly abn Mild Diastolic dysfunction (DD) Low PASP E/e on exercise MOST DIFFICULT TO DIAGNOSE LOWEST RISK VOLUME OVERLOAD PULMONARY HYPERTENSION/RV FAILURE Shah, SJ. JACC 2013 NYHA III Mild/moderate leg edema/rales Recent HF hospitalization Elevated BNP/NT-proBNP Moderate DD PASP moderately elevated NYHA III Severe edema/ dyspnea at rest/ascites Frequent hospitalizations Moderate/Severe DD Multivalvular lesions, RV dysfunction Most common phenotype enrolled in trials Diagnosis may be missed, especially in obese/lung disease RHC can be useful PASP significantly elevated PAH on top of pulmonary venous hypertension Highest BNP HIGHEST RISK
Diagnosis is it really Heart Failure?
ESC Congress Munich - 25-29 August 2012 Heart Failure with Preserved Ejection Fraction From Bench to Bedside Diagnosis is it really Heart Failure? Prof. Burkert Pieske Department of Cardiology Med.University
More informationΜαρία Μπόνου Διευθύντρια ΕΣΥ, ΓΝΑ Λαϊκό
Μαρία Μπόνου Διευθύντρια ΕΣΥ, ΓΝΑ Λαϊκό Diastolic HF DD: Diastolic Dysfunction DHF: Diastolic HF HFpEF: HF with preserved EF DD Pathophysiologic condition: impaired relaxation, LV compliance, LV filling
More informationTHE PROPER APPROACH TO DIAGNOSING HEART FAILURE WITH PRESERVED EJECTION FRACTION
THE PROPER APPROACH TO DIAGNOSING HEART FAILURE WITH PRESERVED EJECTION FRACTION James C. Fang, MD, FACC Professor and Chief Cardiovascular Division University of Utah School of Medicine Disclosures Data
More informationAn Integrated Approach to Study LV Diastolic Function
An Integrated Approach to Study LV Diastolic Function Assoc. Prof. Adriana Ilieşiu, FESC University of Medicine Carol Davila Bucharest, Romania LV Diastolic Dysfunction impaired relaxation (early diastole)
More informationObjectives. Systolic Heart Failure: Definitions. Heart Failure: Historical Perspective 2/7/2009
Objectives Diastolic Heart Failure and Indications for Echocardiography in the Asian Population Damon M. Kwan, MD UCSF Asian Heart & Vascular Symposium 02.07.09 Define diastolic heart failure and differentiate
More informationDECLARATION OF CONFLICT OF INTEREST
DECLARATION OF CONFLICT OF INTEREST ESC Congress 2011 Pathophysiology of HFPEF Vascular Remodeling & Pulmonary Hypertension Carolyn S.P. Lam MBBS, MRCP, MS Case Presentation 81 yo woman with dyspnoea &
More informationLeft ventricular diastolic function and filling pressure in patients with dilated cardiomyopathy
Left ventricular diastolic function and filling pressure in patients with dilated cardiomyopathy Bogdan A. Popescu University of Medicine and Pharmacy Bucharest, Romania My conflicts of interest: I have
More informationHFpEF. April 26, 2018
HFpEF April 26, 2018 (J Am Coll Cardiol 2017;70:2476 86) HFpEF 50% or more (40-71%) of patients with CHF have preserved LV systolic function. HFpEF is an increasingly frequent hospital discharge. Outcomes
More informationTherapeutic Targets and Interventions
Therapeutic Targets and Interventions Ali Valika, MD, FACC Advanced Heart Failure and Pulmonary Hypertension Advocate Medical Group Midwest Heart Foundation Disclosures: 1. Novartis: Speaker Honorarium
More informationHeart Failure in Women: Dr Goh Ping Ping Cardiologist Asian Heart & Vascular Centre
Heart Failure in Women: More than EF? Dr Goh Ping Ping Cardiologist Asian Heart & Vascular Centre Overview Review pathophysiology as it relates to diagnosis and management Rational approach to workup:
More informationΒασιλική Κατσή. Καρδιολόγος ΓNA Ιπποκράτειο
Βασιλική Κατσή Καρδιολόγος ΓNA Ιπποκράτειο 40 διαφάνειες ίσως Και πρέπει και δικαιούνται ΣΥΧΝΟΤΕΡΑ 76-96% 3343 men and 4199 women followed for 25 years, no HF at baseline BP (mm Hg)
More informationDiastolic Heart Failure Uri Elkayam, MD
Diastolic Heart Failure Uri Elkayam, MD Professor of Medicine University of Southern California School of Medicine Los Angeles, California elkayam@usc.edu Diastolic Heart Failure Clinical Definition A
More informationEvaluation of Left Ventricular Diastolic Dysfunction by Doppler and 2D Speckle-tracking Imaging in Patients with Primary Pulmonary Hypertension
ESC Congress 2011.No 85975 Evaluation of Left Ventricular Diastolic Dysfunction by Doppler and 2D Speckle-tracking Imaging in Patients with Primary Pulmonary Hypertension Second Department of Internal
More informationRestrictive Cardiomyopathy
ESC Congress 2011, Paris Imaging Unusual Causes of Cardiomyopathy Restrictive Cardiomyopathy Kazuaki Tanabe, MD, PhD Professor of Medicine Chair, Division of Cardiology Izumo, Japan I Have No Disclosures
More informationLCZ696 A First-in-Class Angiotensin Receptor Neprilysin Inhibitor
The Angiotensin Receptor Neprilysin Inhibitor LCZ696 in Heart Failure with Preserved Ejection Fraction The Prospective comparison of ARNI with ARB on Management Of heart failure with preserved ejection
More informationImaging in Heart Failure: A Multimodality Approach. Thomas Ryan, MD
Imaging in Heart Failure: A Multimodality Approach Thomas Ryan, MD Heart Failure HFrEF HFpEF EF50% Lifetime risk 20% Prevalence 6M Americans Societal costs - $30B 50% 5-year survival 1 Systolic
More informationVECTORS OF CONTRACTION
1/3/216 Strain, Strain Rate, and Torsion: Myocardial Mechanics Simplified and Applied VECTORS OF CONTRACTION John Gorcsan, MD University of Pittsburgh, Pittsburgh, PA Shortening Thickening Twisting No
More informationThe right heart: the Cinderella of heart failure
The right heart: the Cinderella of heart failure Piotr Ponikowski, MD, PhD, FESC Medical University, Centre for Heart Disease Clinical Military Hospital Wroclaw, Poland none Disclosure Look into the Heart
More informationHeart Failure with preserved ejection fraction (HFpEF)
Heart Failure with preserved ejection fraction (HFpEF) Dr. Pierpaolo Pellicori Hull York Medical School Kingston-upon-Hull United Kingdom Conflict of interest: none Heart failure is a contemporary problem
More informationΗ ηχωκαρδιολογία στην διάγνωση κα πρόγνωση της καρδιακής ανεπάρκειας µε µειωµένο και φυσιολογικό κλάσµα εξώθησης
Η ηχωκαρδιολογία στην διάγνωση κα πρόγνωση της καρδιακής ανεπάρκειας µε µειωµένο και φυσιολογικό κλάσµα εξώθησης Βασίλειος Σαχπεκίδης Επιµελητής Β Καρδιολογίας Γ.Ν. Παπαγεωργίου Θεσσαλονίκη ESC Guidelines
More informationEjection Fraction in Patients With Chronic Heart Failure. Diastolic Heart Failure or Heart Failure with Preserved Ejection Fraction
Diastolic Heart Failure or Heart Failure with Preserved Ejection Fraction Keith Miller MD Diastolic Heart Failure Risk Factors Common Risk Factors Aging Female gender Obesity Hypertension Diabetes mellitus
More informationTreating the patient with acute heart failure. What do we really know? Principles of acute heart failure treatment
ESC 2012 27Aug - 3Sep, 2012, Munich, Germany Treating the patient with acute heart failure. What do we really know? Principles of acute heart failure treatment Marco Metra, MD, FESC Cardiology University
More informationThe new Guidelines: Focus on Chronic Heart Failure
The new Guidelines: Focus on Chronic Heart Failure Petros Nihoyannopoulos MD, FRCP, FESC Professor of Cardiology Imperial College London and National & Kapodistrian University of Athens 2 3 4 The principal
More informationHow to Assess Diastolic Dysfunction?
How to Assess Diastolic Dysfunction? Fausto J Pinto, MD, PhD, FESC, FACC, FASE Lisbon University Dyastolic Dysfunction Impaired relaxation Elevated filling pressures Ischemic heart disease Cardiomyopathies
More informationConflicts of interest: GE, Abbott, Edwards (honoraria)
Understanding Diastole and Its Contribution to Heart Failure: State of the Art in 2016 James D. Thomas, MD, FACC, FASE Director, Center for Heart Valve Disease Bluhm Cardiovascular Institute Professor
More informationHFpEF, Mito or Realidad?
HFpEF, Mito or Realidad? Ileana L. Piña, MD, MPH Professor of Medicine and Epidemiology/Population Health Associate Chief for Academic Affairs -- Cardiology Montefiore-Einstein Medical Center Bronx, NY
More informationHFNEF. Heart Failure is
HFNEF Bijoy K. Khandheria, MD. FASE, FACP, FACC FESC Professor of Medicine University of Wisconsin Director. Echocardiography Services Aurora Health Care No conflicts or off label use CP1173868-1 Heart
More informationSleep Disordered Breathing and HH with Preserved Ejection Fraction:
Sleep Disordered Breathing and HH with Preserved Ejection Fraction: Pr Thibaud DAMY Heart Failure Unit Department of Cardiology CHU Mondor, Créteil, France Definition of HF-PEF The diagnosis of HF-PEF
More informationDr.Fayez EL Shaer Consultant cardiologist Assistant professor of cardiology KKUH
Pulmonary Hypertension in patients with Heart Failure with Preserved Ejection Fraction Dr.Fayez EL Shaer Consultant cardiologist Assistant professor of cardiology KKUH Recent evaluation of available data
More informationHF-Preserved Ejection Fraction
HF-Preserved Ejection Fraction Justin A. Ezekowitz, MBBCh MSc FRCPC FACC FESC FAHA Associate Professor, University of Alberta Co-Director, Canadian VIGOUR Centre Cardiologist, Mazankowski Alberta Heart
More informationThe Patient with Atrial Fibrilation
Assessment of Diastolic Function The Patient with Atrial Fibrilation Assoc. Prof. Adriana Ilieşiu, FESC University of Medicine Carol Davila Bucharest, Romania Associated Conditions with Atrial Fibrillation
More informationTissue Doppler and Strain Imaging
Tissue Doppler and Strain Imaging Steven J. Lester MD, FRCP(C), FACC, FASE Relevant Financial Relationship(s) None Off Label Usage None 1 Objective way with which to quantify the minor amplitude and temporal
More informationNatural History and Echo Evaluation of Aortic Stenosis
Natural History and Echo Evaluation of Aortic Stenosis Prof. Patrizio LANCELLOTTI, MD, PhD Heart Valve Clinic, University of Liège, CHU Sart Tilman, Liège, BELGIUM AORTIC STENOSIS First valvular disease
More informationTissue Doppler and Strain Imaging
Tissue Doppler and Strain Imaging Steven J. Lester MD, FRCP(C), FACC, FASE Relevant Financial Relationship(s) None Off Label Usage None 1 Objective way with which to quantify the minor amplitude and temporal
More informationEjection across stenotic aortic valve requires a systolic pressure gradient between the LV and aorta. This places a pressure load on the LV.
Valvular Heart Disease Etiology General Principles Cellular and molecular mechanism of valve damage Structural pathology Functional pathology - stenosis/regurgitation Loading conditions - pressure/volume
More informationGENERAL PRINCIPLES FOR ECHO ASSESSMENT OF DIASTOLIC FUNCTION (For full recommendation refer to the Left Ventricular Diastolic Function Guideline)
1 THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY RECOMMENDATIONS FOR THE EVALUATION OF LEFT VENTRICULAR DIASTOLIC FUNCTION BY ECHOCARDIOGRAPHY: A QUICK REFERENCE GUIDE FROM THE ASE WORKFLOW AND LAB MANAGEMENT
More informationEvalua&on)of)Le-)Ventricular)Diastolic) Dysfunc&on)by)Echocardiography:) Role)of)Ejec&on)Frac&on)
Evalua&on)of)Le-)Ventricular)Diastolic) Dysfunc&on)by)Echocardiography:) Role)of)Ejec&on)Frac&on) N.Koutsogiannis) Department)of)Cardiology) University)Hospital)of)Patras)! I have no conflicts of interest
More informationDiastolic Heart Function: Applying the New Guidelines Case Studies
Diastolic Heart Function: Applying the New Guidelines Case Studies Mitral Regurgitation The New ASE William Guidelines: A. Zoghbi Role MD, of FASE, 2D/3D MACCand CMR Professor and Chairman, Department
More informationDiastolic Function Assessment New Guideline Update Practical Approach
Mayo Clinic Department of Cardiovascular Diseases Mayo Clinic Echocardiography Review Course for Boards and Recertification Diastolic Function Assessment New Guideline Update Practical Approach Jae K.
More informationNew in Heart Failure SGK autumn session 2012
New in Heart Failure SGK autumn session 2012 Roger Hullin Cardiology Department of Internal Medicine Centre Universitaire Hospitaler Vaudois University of Lausanne ESC Heart Failure Guidelines 2012 Classes
More informationEjection across stenotic aortic valve requires a systolic pressure gradient between the LV and aorta. This places a pressure load on the LV.
Valvular Heart Disease General Principles Etiology Cellular and molecular mechanism of valve damage Structural pathology Functional pathology - stenosis/regurgitation Loading conditions - pressure/volume
More informationValue of echocardiography in chronic dyspnea
Value of echocardiography in chronic dyspnea Jahrestagung Schweizerische Gesellschaft für /Schweizerische Gesellschaft für Pneumologie B. Kaufmann 16.06.2016 Chronic dyspnea Shortness of breath lasting
More informationΟξεία καρδιακή ανεπάρκεια: Ποιες παράμετροι συμβάλλουν στη διαστρωμάτωση κινδύνου των ασθενών;
Οξεία καρδιακή ανεπάρκεια: Ποιες παράμετροι συμβάλλουν στη διαστρωμάτωση κινδύνου των ασθενών; Γ. Φιλιππάτος, MD, FACC, FESC, FCCP Επ. Καθηγητής Καρδιολογίας Πανεπ. Αθηνών Clinical Outcomes in Patients
More informationObjectives. Let s start at the beginning 10/28/2014. What is Heart Failure? Understanding Heart Failure with Preserved LV Systolic Function
Understanding Heart Failure with Preserved LV Systolic Function Eric Ernst, MD Medical Director C.O.R.E. Clinic Objectives Clarify the terminology surrounding right heart failure and diastolic heart failure
More informationAtrial dyssynchrony syndrome: An overlooked cause of heart failure with normal ejection fraction
Atrial dyssynchrony syndrome: An overlooked cause of heart failure with normal ejection fraction JC Eicher, G Laurent, O Barthez, A Mathé, G Bertaux, JE Wolf Heart Failure Treatment Unit, Rhythmology and
More informationHFpEF: Pathophysiology & Treatment
HFpEF: Pathophysiology & Treatment Barry A. Borlaug, MD Mayo Clinic, Rochester, MN borlaug.barry@mayo.edu Disclosure Financial Relationships Research Support: Aires Pharmaceuticals, Medtronic, GSK Consulting/Advisory
More informationDiastology State of The Art Assessment
Diastology State of The Art Assessment Dr. Mohammad AlGhamdi Assistant professor, KSAU-HS Consultant Cardiologist King AbdulAziz Cardiac Center Ministry of National Guard Health Affairs Diagnostic Clinical
More informationDiastolic Heart Failure (HFpEF) Felix J. Rogers, DO, FACOI April 29, 2018
Diastolic Heart Failure (HFpEF) Felix J. Rogers, DO, FACOI April 29, 2018 Case presentation MSO, an 81 year old woman was admitted to HFWH because of progressive dyspnea and difficult to control hypertension
More informationHeart Failure with Preserved EF (HFPEF) Epidemiology and management
Heart Failure with Preserved EF (HFPEF) Epidemiology and management Karl Swedberg Senior Professor of Medicine Sahlgrenska Academy University of Gothenburg Gothenburg, Sweden e-mail: karl.swedberg@gu.se
More informationMechanisms of heart failure with normal EF Arterial stiffness and ventricular-arterial coupling. What is the pathophysiology at presentation?
Mechanisms of heart failure with normal EF Arterial stiffness and ventricular-arterial coupling What is the pathophysiology at presentation? Ventricular-arterial coupling elastance Central arterial pressure
More informationDr. Dermot Phelan MB BCh BAO PhD European Society of Cardiology 2012
Relative Apical Sparing of Longitudinal Strain Using 2- Dimensional Speckle-Tracking Echocardiography is Both Sensitive and Specific for the Diagnosis of Cardiac Amyloidosis. Dr. Dermot Phelan MB BCh BAO
More informationΒΙΟΔΕΙΚΤΕΣ ΣΤΗΝ ΚΑΡΔΙΑΚΗ ΑΝΕΠΑΡΚΕΙΑ. ΔΗΜΗΤΡΙΟΣ ΤΟΥΣΟΥΛΗΣ Καθηγητής Καρδιολογίας
ΕΘΝΙΚΟ ΚΑΙ ΚΑΠΟΔΙΣΤΡΙΑΚΟ ΠΑΝΕΠΙΣΤΗΜΙΟ ΑΘΗΝΩΝ ΙΑΤΡΙΚΗ ΣΧΟΛΗ Ά ΚΑΡΔΙΟΛΟΓΙΚΗ ΚΛΙΝΙΚΗ Διευθυντής: Καθηγητής Δημήτριος Τούσουλης ΒΙΟΔΕΙΚΤΕΣ ΣΤΗΝ ΚΑΡΔΙΑΚΗ ΑΝΕΠΑΡΚΕΙΑ ΔΗΜΗΤΡΙΟΣ ΤΟΥΣΟΥΛΗΣ Καθηγητής Καρδιολογίας
More informationLV FUNCTION ASSESSMENT: WHAT IS BEYOND EJECTION FRACTION
LV FUNCTION ASSESSMENT: WHAT IS BEYOND EJECTION FRACTION Jamilah S AlRahimi Assistant Professor, KSU-HS Consultant Noninvasive Cardiology KFCC, MNGHA-WR Introduction LV function assessment in Heart Failure:
More informationESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure
Patients t with acute heart failure frequently develop chronic heart failure Patients with chronic heart failure frequently decompensate acutely ESC Guidelines for the Diagnosis and A clinical response
More informationExercise Testing/Echocardiography in Asymptomatic AS
Exercise Testing/Echocardiography in Asymptomatic AS Raluca Dulgheru, MD Heart Valve Clinic, University of Liège, CHU Sart Tilman, BELGIUM Disclosure related to this presentation: None VALVULAR HEART DISEASE
More informationAcute heart failure syndromes: clinical challenges. Pathophysiology. ESC Congress August. Paris, France. Marco Metra
ESC Congress 2011 27-31 August. Paris, France. Acute heart failure syndromes: clinical challenges. Pathophysiology Marco Metra Cardiology, Dept. Of experimental and applied medicine. University of Brescia.
More informationΝεότερα ςτην Υπερηχοκαρδιογραφία. Βαςίλειοσ Καμπερίδησ Clinical research fellow in Cardiology
Νεότερα ςτην Υπερηχοκαρδιογραφία Βαςίλειοσ Καμπερίδησ Clinical research fellow in Cardiology Disclosures ESC training grant EACVI research grant HCS training grant ELIKAR research grant Evolution of Echocardiography
More informationStrain Imaging: Myocardial Mechanics Simplified and Applied
9/28/217 Strain Imaging: Myocardial Mechanics Simplified and Applied John Gorcsan III, MD Professor of Medicine Director of Clinical Research Division of Cardiology VECTORS OF CONTRACTION Shortening Thickening
More informationHeFSSA Practitioners Program 2017 Theme The Patient Journey: Feel Good and Live Long. Case Study 2
HeFSSA Practitioners Program 2017 Theme The Patient Journey: Feel Good and Live Long Case Study 2 HEART FAILURE WITH MID-RANGE EJECTION FRACTION TREATMENT OPTIONS CLINICAL CASE MEDICAL HISTORY 59-year-old
More informationDiastolic Function Assessment Practical Ways to Incorporate into Every Echo
Diastolic Function Assessment Practical Ways to Incorporate into Every Echo Jae K. Oh, MD Echo Hawaii 2018 2018 MFMER 3712003-1 Learning Objectives My presentation will help you to Appreciate the importance
More informationTissue Doppler and Strain Imaging. Steven J. Lester MD, FRCP(C), FACC, FASE
Tissue Doppler and Strain Imaging Steven J. Lester MD, FRCP(C), FACC, FASE Relevant Financial Relationship(s) None Off Label Usage None a. Turn the wall filters on and turn down the receiver gain. b. Turn
More informationΔυναμική υπερηχοκαρδιογραφία στις μυοκαρδιοπάθειες : έχει θέση και ποια ;
Ελληνική Καρδιολογική Εταιρεία Σεμινάρια ομάδων εργασίας Θεσσαλονίκη, 8-10 Φεβρουαρίου 2018 Ομάδα εργασίας Ηχωκαρδιολογίας Δυναμική υπερηχοκαρδιογραφία στις μυοκαρδιοπάθειες : έχει θέση και ποια ; ΑΓΑΘΗ-ΡΟΖΑ
More informationHighlights from EuroEcho 2009 Echo in cardiomyopathies
Highlights from EuroEcho 2009 Echo in cardiomyopathies Bogdan A. Popescu University of Medicine and Pharmacy, Bucharest, Romania ESC Congress 2010 Hypertrophic cardiomyopathy To determine the differences
More informationMihai Gheorghiade MD
Mihai Gheorghiade MD Center for Cardiovascular Innovation, Northwestern University Feinberg School of Medicine, Chicago, Illinois On behalf of: Stephen J Greene MD; Javed Butler MD MPH MBA; Gerasimos Filippatos
More informationECHO HAWAII. Role of Stress Echo in Valvular Heart Disease. Not only ischemia! Cardiomyopathy. Prosthetic Valve. Diastolic Dysfunction
Role of Stress Echo in Valvular Heart Disease ECHO HAWAII January 15 19, 2018 Kenya Kusunose, MD, PhD, FASE Tokushima University Hospital Japan Not only ischemia! Cardiomyopathy Prosthetic Valve Diastolic
More informationHeart Failure with Preserved Left Ventricular Ejection Fraction. (HFpEF)
Thessaloniki, May 27, 2017 Heart Failure with Preserved Left Ventricular Ejection Fraction Filippos Triposkiadis, MD, FESC, FACC Professor of Cardiology Director, Department of Cardiology Larissa University
More informationThe right ventricle in chronic heart failure
The right ventricle in chronic heart failure ESC 2012 Christian Opitz, Berlin There are no conflicts of interest relevant to this presentation Percent of Population Prevalence of Heart Failure by Age and
More informationTHE DIASTOLIC STRESS TEST: A NEW CLINICAL TOOL? THE CONCEPT OF DIASTOLIC RESERVE
Thierry C. Gillebert University of Ghent ESC Education Committee THE DIASTOLIC STRESS TEST: A NEW CLINICAL TOOL? THE CONCEPT OF DIASTOLIC RESERVE 1 Case: Ann, 63 years Suffered from metabolic syndrome
More informationHeart Failure with Preserved Ejection Fraction (HFpEF): Natural History and Contemporary Management
Heart Failure with Preserved Ejection Fraction (HFpEF): Natural History and Contemporary Management Jason L. Guichard, MD, PhD Greenville Health System Department of Medicine, Carolina Cardiology Consultants
More informationDiastolic Heart Failure
Chronic Heart Failure Prevalence overall = 2-3 % Diastolic Heart Failure Patrick Wouters University Hospital Ghent Belgium (Heart Failure + Asymptomatic Ventricular Dysfunction) Prevalence > 70 y = 10-20
More informationReview of Cardiac Imaging Modalities in the Renal Patient. George Youssef
Review of Cardiac Imaging Modalities in the Renal Patient George Youssef ECHO Left ventricular hypertrophy (LVH) assessment Diastolic dysfunction Stress ECHO Cardiac CT angiography Echocardiography - positives
More informationWhat to do for the Patient with Heart Failure and Preserved Ejection Fraction: HFpEF
What to do for the Patient with Heart Failure and Preserved Ejection Fraction: HFpEF Mariell Jessup MD, FAHA, FACC, FESC Professor of Medicine University of Pennsylvania Philadelphia, Pennsylvania Disclosure:
More informationHeart Failure Guidelines For your Daily Practice
Heart Failure Guidelines For your Daily Practice Juan M. Aranda, Jr., MD, FACC, FHFSA Professor of Medicine Director of Heart Failure and Cardiac Transplantation University of Florida College of Medicine
More informationΟξεία Καρδιακή Ανεπάρκεια: Κλινική εικόνα, ταξινόμηση κινδύνου & προγνωστικοί δείκτες
Οξεία Καρδιακή Ανεπάρκεια: Κλινική εικόνα, ταξινόμηση κινδύνου & προγνωστικοί δείκτες Στράτος Θεοφιλογιαννάκος, MD, PhD Ιατρείο Καρδιακής Ανεπάρκειας, Γ Πανεπιστημιακή Καρδιολογική Κλινική ΑΠΘ, ΠΓΝ Ιπποκράτειο
More informationThe importance of left atrium in LV diastolic function
II Baltic Heart Failure Meeting and Congress of Latvian Society of Cardiology The importance of left atrium in LV diastolic function Dr. Artem Kalinin Eastern Clinical University Hospital Riga 30.09.2010.
More informationSystolic and Diastolic Dysfunction: Four Upcoming Challenges
Systolic and Diastolic Dysfunction: Four Upcoming Challenges Promoting Early Detection HFrEF: Beyond Neprilysin/Enalapril HFmrEF: What Is It and How Does One Manage It? HFpEF: Etiopathogenetic Role and
More informationHeart Failure in Women
Heart Failure in Women Disclosure Professor Sindone has received honoraria, speaker fees, consultancy fees, is a member of advisory boards or has appeared on expert panels for: Professor Andrew Sindone
More informationHFpEF: How to optimise management
HFpEF: How to optimise management Burkert Pieske M.D. Berlin, Germany Department of Internal Medicine and Cardiology, Campus Virchow Klinikum, Charité University Medicine Berlin, and Department of Internal
More informationManagement of chronic heart failure: update J. Parissis Attikon University Hospital
Management of chronic heart failure: update 2015 J. Parissis Attikon University Hospital Disclosures: received honoraria for lectures from Servier, Pfizer, Novartis Discharges in Thousands Heart Failure
More informationPathophysiology: Heart Failure
Pathophysiology: Heart Failure Mat Maurer, MD Irving Assistant Professor of Medicine Outline Definitions and Classifications Epidemiology Muscle and Chamber Function Pathophysiology Heart Failure: Definitions
More informationPreserved EF with heart failure (HF pef) 50% 5 year survival. Both have type 2 diabetes Both have hypertension Both have normal ejection fractions
Research companies Government / University research Preserved EF with heart failure (HF pef) 50% 5 year survival Both have type 2 diabetes Both have hypertension Both have normal ejection fractions Introduction
More informationOutline. Pathophysiology: Heart Failure. Heart Failure. Heart Failure: Definitions. Etiologies. Etiologies
Outline Pathophysiology: Mat Maurer, MD Irving Assistant Professor of Medicine Definitions and Classifications Epidemiology Muscle and Chamber Function Pathophysiology : Definitions An inability of the
More informationHFPEF Echo with Strain vs. MRI T1 Mapping
HFPEF Echo with Strain vs. MRI T1 Mapping Erik Schelbert, MD MS Director, Cardiovascular Magnetic Resonance Assistant Professor of Medicine Heart & Vascular Institute University of Pittsburgh Disclosures
More informationImaging in dilated cardiomyopathy : factors associated with a poor outcome
Imaging in dilated cardiomyopathy : factors associated with a poor outcome Johan De Sutter, MD, PhD, FESC AZ Maria Middelares Gent and University Gent - Belgium Dilated cardiomyopathy Cardiomyopathy with
More informationLoad and Function - Valvular Heart Disease. Tom Marwick, Cardiovascular Imaging Cleveland Clinic
Load and Function - Valvular Heart Disease Tom Marwick, Cardiovascular Imaging Cleveland Clinic Indications for surgery in common valve lesions Risks Operative mortality Failed repair - to MVR Operative
More informationAssessing Function by Echocardiography in VHD Asymptomatic Severe Organic MR. Dr. Julien Magne, PhD Sart Tilman Liège, BELGIUM
Assessing Function by Echocardiography in VHD Asymptomatic Severe Organic MR Dr. Julien Magne, PhD Sart Tilman Liège, BELGIUM Conflict of Interest Disclosure None Why to assess LV function in asymptomatic
More informationHypertensive heart disease and failure
Hypertensive heart disease and failure Prof. Dr. Alan Fraser Cardiff University The heart in hypertension Pathophysiology of LV adaptation Regional development of hypertrophy Stress testing - inducible
More informationMitral Valve prolapse: What s new? Which indications of early surgery? Input of new 2017 ESC/EACTS guidelines. Christophe Tribouilloy Amiens, France
Mitral Valve prolapse: What s new? Which indications of early surgery? Input of new 2017 ESC/EACTS guidelines Christophe Tribouilloy Amiens, France I have no financial relationships to disclose related
More informationHeart Failure with Preserved Ejection Fraction. April 4, 2018 Mike Muellerleile M.D.
Heart Failure with Preserved Ejection Fraction April 4, 2018 Mike Muellerleile M.D. Heart Failure with Preserved Ejection Fraction Introduction Clinical Description of HFpEF Pathophysiology of HFpEF
More informationAtrial dysfunction and chronotropic incompetence
Pathophysiology of heart failure with preserved ejection fraction Atrial dysfunction and chronotropic incompetence Vojtech Melenovsky IKEM, Prague, Czech Republic DECLARATION OF CONFLICT OF INTEREST :
More informationClinical implication of exercise pulmonary hypertension: when should we measure it?
Clinical implication of exercise pulmonary hypertension: when should we measure it? Jang-Young, Kim Wonju College of Medicine, Yonsei Univ. Exercise pulmonary hypertension (EPH) Introduction of pulmonary
More informationHFpEF 2016 : Comorbidities and Outcomes
HFpEF 2016 : Comorbidities and Outcomes Christopher M. O Connor, MD, FACC CEO and Executive Director, Inova Heart and Vascular Institute Professor of Medicine, Duke University Editor in Chief, JACC: Heart
More informationAortic stenosis aetiology: morphology of calcific AS,
How to improve patient selection in aortic stenosis? Fausto J. Pinto, FESC Aortic stenosis aetiology: morphology of calcific AS, bicuspid valve, and rheumatic AS (Adapted from C. Otto, Principles of
More informationDiastolic Function Overview
Diastolic Function Overview Richard Palma BS, RDCS, RCS, APS, FASE Director and Clinical Coordinator The Hoffman Heart and Vascular Institute School of Cardiac Ultrasound None Disclosures Learning Objectives
More informationChoose the grading of diastolic function in 82 yo woman
Question #1 Choose the grading of diastolic function in 82 yo woman E= 80 cm/s A= 70 cm/s LAVI < 34 ml/m 2 1= Grade 1 2= Grade 2 3= Grade 3 4= Normal 5= Indeterminate 2018 MFMER 3712003-1 Choose the grading
More informationLV geometric and functional changes in VHD: How to assess? Mi-Seung Shin M.D., Ph.D. Gachon University Gil Hospital
LV geometric and functional changes in VHD: How to assess? Mi-Seung Shin M.D., Ph.D. Gachon University Gil Hospital LV inflow across MV LV LV outflow across AV LV LV geometric changes Pressure overload
More informationEjection Fraction in Heart Failure: A Redefinition. Tarek Kashour King Fahad Cardiac Center King Saud University Riyadh, KSA
Ejection Fraction in Heart Failure: A Redefinition Tarek Kashour King Fahad Cardiac Center King Saud University Riyadh, KSA Word of caution!!! Incomplete understanding of a disease process may lead to
More informationThe difficult patient with mitral regurgitation
Clinical pathways The difficult patient with mitral regurgitation Stress echo can be the best tool Challenging cases Maria João Andrade, Lisbon PT Management of Severe Chronic Organic MR Echo Exercise
More informationHeart Failure. Cardiac Anatomy. Functions of the Heart. Cardiac Cycle/Hemodynamics. Determinants of Cardiac Output. Cardiac Output
Cardiac Anatomy Heart Failure Professor Qing ZHANG Department of Cardiology, West China Hospital www.blaufuss.org Cardiac Cycle/Hemodynamics Functions of the Heart Essential functions of the heart to cover
More informationConstriction vs Restriction Case-based Discussion
Mayo Clinic Department of Cardiovascular Diseases Mayo Clinic Echocardiography Review Course for Boards and Recertification Constriction vs Restriction Case-based Discussion Jae K. Oh, MD Samsung Professor
More information